STOCK TITAN
  1. Home
  2. Sec-filings
  3. BGMS
  4. [8-K] Bio Green Med Solution, Inc. Reports Material Event

Bio Green Med Solution (NASDAQ: BGMS) sets $0.15 quarterly preferred dividend

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Bio Green Med Solution, Inc. announced that its board of directors declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. The dividend will be paid on August 1, 2026 to preferred stockholders of record at the close of business on July 23, 2026.

Positive

  • None.

Negative

  • None.

Insights

Bio Green Med declares a routine preferred stock dividend.

Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. This reflects the company continuing scheduled payments on this class of securities.

The filing specifies a payment date of August 1, 2026 for stockholders of record on July 23, 2026. The event concerns only the preferred stock class and does not change terms for common shareholders in this disclosure.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Quarterly dividend $0.15 per share Cash dividend on 6% Convertible Exchangeable Preferred Stock
Dividend pay date August 1, 2026 Preferred dividend payment date
Dividend record date July 23, 2026 Stockholders of record date for preferred dividend
6% Convertible Exchangeable Preferred Stock financial
"a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock"
A 6% convertible exchangeable preferred stock is a type of preferred share that pays a fixed 6% annual dividend and gives the holder the right to swap those shares for common stock or other specified securities at a predetermined rate. It matters to investors because it offers steady income like a bond while also providing the potential upside of converting into equity, but it can dilute existing shareholders and changes a company’s capital mix.
quarterly cash dividend financial
"declared a quarterly cash dividend of $0.15 per share"
A quarterly cash dividend is a payment made by a company to its shareholders four times a year, usually based on its profits. It is like a regular bonus or reward for owning the company's stock, providing shareholders with income. Many investors see these payments as a sign of the company's stability and its ability to generate consistent profits.
Emerging growth company regulatory
"Emerging growth company Item 8.01 Other Events."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
The Nasdaq Capital Market market
"Common Stock, par value $0.001 per share | | BGMS | | The Nasdaq Capital Market"
A tier of the Nasdaq stock exchange that hosts smaller or early-stage public companies that meet defined listing standards for size, share price and governance. Think of it as a particular shelf in a store for emerging brands: it gives investors a centralized place to find and trade these stocks while signaling that the companies meet basic regulatory and financial rules. Investors watch it for growth opportunities and higher volatility compared with larger markets.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
false 0001130166 0001130166 2026-07-01 2026-07-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

July 1, 2026

Date of Report (date of earliest event reported)

 

 

Bio Green Med Solution, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware   0-50626   91-1707622

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification Number)

 

Level 10, Tower 11, Avenue 5, No. 8

Jalan Kerinchi, Kuala Lumpur, Malaysia 59200

(Address of principal executive offices) (Zip code)

 

(908) 955-0526

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   BGMS   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01 Other Events.

 

On July 1, 2026, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend is payable on August 1, 2026, to Preferred Stock stockholders of record as of the close of business on July 23, 2026.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: July 1, 2026 Bio Green Med Solution, Inc.
     
  By: /s/ Datuk Dr. Doris Wong Sing Ee
  Name: Datuk Dr. Doris Wong Sing Ee
  Title: Chief Executive Officer and Executive Director

 

 

 

Source: View Original Filing on SEC EDGAR

FAQ

What dividend did Bio Green Med Solution (BGMS) declare on its preferred stock?

Bio Green Med Solution declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. This reflects scheduled income to preferred holders for the current quarter.

When will BGMS pay the latest preferred stock dividend?

The preferred stock dividend will be paid on August 1, 2026. Holders of the 6% Convertible Exchangeable Preferred Stock as of the stated record date will receive the cash payment on that date.

What is the record date for Bio Green Med Solution’s preferred dividend?

The record date for the preferred stock dividend is July 23, 2026. Investors owning the 6% Convertible Exchangeable Preferred Stock at the close of business that day will qualify for the August 1, 2026 payment.

Which security class receives the new BGMS dividend?

The dividend applies to Bio Green Med Solution’s 6% Convertible Exchangeable Preferred Stock. Common stock is not mentioned in this dividend declaration and therefore is not covered by this specific cash distribution.

Is the BGMS dividend a one-time payment or part of a series?

The company describes the payment as a quarterly cash dividend on its 6% Convertible Exchangeable Preferred Stock. That wording indicates it is part of a recurring dividend schedule for this preferred class.

Filing Exhibits & Attachments

3 documents

Other Documents